Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Julius A. Kasel"'
Autor:
Edwin D. Kilbourne, Bert E. Johansson, John H. Quarles, Robert B. Couch, Julius A. Kasel, Barbara A. Pokorny, Thomas R. Cate, Bemardo Grajower, Wendy A. Keitel
Publikováno v:
Vaccine. 13:1799-1803
The immunogenicity and toxicity of a purified influenza virus (N2) neuraminidase vaccine (NAV) were investigated in 88 human subjects aged 18-40, and compared to response to a conventional trivalent influenza vaccine, Fluogen (Parke-Davis). NAV doses
Autor:
Raphael, Dolin, Neil R, Blacklow, Herbert, DuPont, Samuel, Formal, Robert F, Buscho, Julius A, Kasel, Robert P, Chames, Richard, Hornick, Robert M, Chanock
Publikováno v:
The Journal of infectious diseases. 189(11)
Autor:
Deborah A. Hogerman, R C Welliver, A M Jewel, P R Paradiso, Rayford Y, S W Hildreth, Julius A. Kasel, W P Glezen, Pedro A. Piedra
Publikováno v:
Vaccine. 13(12)
PFP-1 vaccine was evaluated in a randomized, controlled study in 47 RSV seropositive children. Trivalent inactivated influenza virus (TIV) vaccine was the control. Vaccine reactions were monitored, and bloods were obtained before vaccination, 4 weeks
Autor:
Hoan-jong Lee, Jin-Won Pyo, Yong Choi, Il-Soo Ha, Julius A. Kasel, Eun-Hwa Choi, Cheong Hi, Pedro A. Piedra
Publikováno v:
The Pediatric Infectious Disease Journal. 15:633-634
Autor:
Julius A. Kasel, Leonard D. Moise, Harold Brown, Donald M. Freeman, Nellie P. Grose, Robert B. Couch
Publikováno v:
Journal of Infectious Diseases. 136:S466-S471
2The immunogenicity and reactogenicity of inactivated influenza A/New Jersey/76 (Hsw1N1) whole-virus vaccine administered intradermally (40 chick cell-agglutinating units/0.1-ml dose) and intramuscularly (im; 200 chick cell-agglutinating units/0.5-ml
Autor:
Julius A. Kasel, Robert B. Couch
Publikováno v:
Annual Review of Microbiology. 37:529-549
The observations summarized in this review indicate immunity to infection with type A influenza viruses is subtype specific since little or none is conveyed to subtypes possessing immunologically distinct HA and NA proteins. However, within a subtype
Publikováno v:
Journal of Infectious Diseases. 136:S518-S525
This placebo-controlled evaluation in elderly persons of inactivated influenza virus vaccines containing 200 or 400 chicke cell-agglutinating units of both A/New Jersey/76 and A/Victoria/75 antigens revealed mild systemic reactions in 7.8% and modera
Publikováno v:
Journal of Infectious Diseases. 134:48-58
Subunit vaccines containing hemagglutinin, neuraminidase, and nucleocapsids of A/Port Chalmers/1/73 (H3N2) influenza virus were prepared after treatment of purified virus with ammonium deoxycholate. The immunogenicity of these subunits and the respon
Publikováno v:
Journal of Clinical Microbiology. 6:19-22
A comparison of Hanks balanced salt solution, veal infusion broth (VIB), and charcoal viral transport medium for maintaining viability of type A influenza virus indicated approximately equal survival of virus on all three media at -70 and 4 degrees C
Publikováno v:
Experimental Biology and Medicine. 169:135-139
Clearance rates of 125I-hexon administered in three different forms from injection sites were assessed in animals. Aqueous and liposome-entrapped hexons following parental administration were cleared in linear fashion with half-lives that ranged from